ArticleTechnology in cancer research & treatment

High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study.

Caiyun Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.